Articles

Results 1 to 5 of 11


Federal Circuit Finds That a Variant Polypeptide Sequence Infringes Under the Doctrine of Equivalents

USA - August 12 2019 In a pair of cross-appeals from the International Trade Commission, the Federal Circuit affirmed the Commission’s ruling that one of CJ CheilJedang…

PTAB holds Genentech’s antibody purification method claims unpatentable as anticipated and obvious

USA - March 9 2018 The PTAB held that all of Genentech’s challenged antibody purification claims were unpatentable as being anticipated, obvious, or both, in an IPR…

Kerry S. Taylor, Ph.D.

Biotech Patent Applications May be Eligible to Receive Benefits From Ongoing USPTO Initiatives

USA - November 1 2017 A pair of ongoing USPTO initiatives, Patents for Humanity and Patents 4 Patients, offer incentives that certain biotechnology patent applications may…

Agnes Juang, Ph.D

FDA re-approves Mylotarg® antibody-drug conjugate seven years after it had been withdrawn from the market

USA - September 11 2017 Seven years after Mylotarg® (gemtuzumab ozogamicin) was voluntarily withdrawn from the market, the U.S. Food and Drug Administration has re-approved…

Eric Furman, Ph.D.

Federal Circuit Finds That Fetal Diagnosis Claims Survive Written Description Attacks

USA - July 17 2017 Stanford University v. The Chinese University of Hong Kong. Federal Circuit Appeal No. 2015-2011. Decided June 27, 2017...

Michael Fuller